Bright Minds Biosciences Shares to Commence Trading on the OTCQB Venture Market on May 17, 2021
VANCOUVER, British Columbia, May 17, 2021 (GLOBE NEWSWIRE) — Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (CSE:DRUG) (OTCQB:BMBIF), a biotechnology company focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and pain, today announced that its shares will commence trading on the OTCQB® Venture Market (the “OTCQB”) on May 17, 2021, under…
